Tenet Healthcare (THC) Set to Announce Quarterly Earnings on Thursday

Key Points

• Tenet Healthcare is expected to report Q3 2026 earnings before the market opens on October 29. Analysts forecast $4.68 in EPS on $5.49 billion in revenue, while management’s full-year EPS guidance is $20.30–$21.69.
• The company’s previous quarter exceeded expectations, with EPS of $6.12 versus the $4.26 consensus and revenue of $6.04 billion, up 6.8% year over year.
• Wall Street maintains a favorable view of THC: 18 analysts rate it Buy and three Hold, producing a “Moderate Buy” consensus and an average price target of $278.45. However, insiders have sold 131,199 shares worth about $35.1 million over the past three months.

Tenet Healthcare (NYSE:THC - Get Free Report) is projected to announce its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect the company to announce earnings of $4.68 per share and revenue of $5.49 billion for the quarter. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Investors can check the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, October 29, 2026 at 10:00 AM ET.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm had revenue of $6.04 billion for the quarter, compared to analysts' expectations of $5.43 billion. During the same quarter last year, the company earned $4.02 EPS. Tenet Healthcare's quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts expect Tenet Healthcare to post $21.04 EPS for the current fiscal year and $20.80 EPS for the next fiscal year.

Tenet Healthcare Stock Down 1.1%

THC stock opened at $269.26 on Thursday. The firm's 50-day moving average is $264.78 and its two-hundred day moving average is $220.99. The company has a market capitalization of $21.68 billion, a price-to-earnings ratio of 10.38, a price-to-earnings-growth ratio of 1.04 and a beta of 1.20. Tenet Healthcare has a 52 week low of $157.58 and a 52 week high of $283.05. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Richard Mark sold 10,000 shares of the business's stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director owned 25,121 shares in the company, valued at approximately $6,617,373.82. The trade was a 28.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director J. Robert Kerrey sold 12,010 shares of the company's stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the sale, the director directly owned 4,794 shares of the company's stock, valued at $1,264,273.68. This represents a 71.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 131,199 shares of company stock worth $35,065,587 in the last three months. Insiders own 0.97% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Guggenheim boosted their target price on Tenet Healthcare from $283.00 to $307.00 and gave the stock a "buy" rating in a report on Friday, October 16th. Leerink Partners reiterated an "outperform" rating and set a $309.00 price target on shares of Tenet Healthcare in a research report on Friday, September 18th. Morgan Stanley boosted their price objective on Tenet Healthcare from $254.00 to $274.00 and gave the stock an "overweight" rating in a research note on Monday, July 27th. BMO Capital Markets initiated coverage on Tenet Healthcare in a research note on Tuesday, September 22nd. They issued a "market perform" rating and a $265.00 price objective on the stock. Finally, TD Cowen upped their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the company a "buy" rating in a report on Monday, July 27th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $278.45.

Tenet Healthcare Company Profile

Tenet Healthcare Corp. NYSE: THC is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.